Background There is no international consensus on how to manage women with a pregnancy of unknown location (PUL).
Introduction
Pain and bleeding in early pregnancy are a common problem in both primary and secondary care. Pregnancy of unknown location (PUL) is a term used to describe a clinical scenario whereby a woman presents with a positive urine pregnancy test but the pregnancy cannot be located on transvaginal ultrasonography (TVS). Clinically, this raises the concern of a possible ectopic pregnancy (EP) that was not seen on the initial ultrasound scan. The reported PUL rate depends on the population studied and the quality of ultrasonography and between 5-42% of women undergoing a scan in early pregnancy fall into this category. 1 The final pregnancy outcome in women classified as having a PUL is either [1] an intrauterine pregnancy (IUP) -whether that be viable (VIUP) or non-viable (NVIUP); [2] a failed PUL (FPUL -when the pregnancy location is never definitively determined but serial serum human chorionic gonadotrophin (hCG) levels decrease in a way that is consistent with a failing pregnancy); [3] an EP (a pregnancy confirmed as being extrauterine either using TVS or on histopathological examination after surgical management); or [4] a persistent PUL (PPUL -when the pregnancy location is never definitively determined but serial serum hCG levels rise/fall < 15% on three consecutive 48-hour samples). 1, 2 The management of women with a PUL is largely based on the risk stratification of clinical complications: final outcomes [1] and [2] putting the woman at a low risk and final outcomes [3] and [4] placing them at high risk. 3 Numerous management protocols have been published, the majority of which are based on the interpretation of serum hCG levels. These include studies on single hCG cutoffs and the hCG ratio (hCG at 48 hours/initial hCG). Our research consortium has published on logistic regression models such as the 'M4 model' 14, 27 that also use the predictive power of hCG. The utility of other clinically used serum biomarkers such as progesterone, [29] [30] [31] [32] novel serum biomarkers, [33] [34] [35] clinical markers such as the amount of vaginal bleeding experienced and ultrasound-based markers such as the endometrial thickness [36] [37] [38] have also been evaluated. There is a lack of clarity for clinicians on which protocol is best and therefore a great deal of heterogeneity in how women with a PUL are managed.
The primary aim of this study was to perform a systematic review and meta-analysis of protocols used for the management of women with a PUL and compare their test performance. A previous meta-analysis published in 2012 only assessed the diagnostic value of serum hCG in managing PUL. 39 This study aimed to compare all published management protocols.
Methods

Protocol and registration
The search methods, inclusion and exclusion criteria, types of studies to be included, outcomes measures, quality assessment and strategy for data synthesis were specified in advance and documented in the study protocol. This was registered with PROSPERO (http://www.crd.york.ac.uk/ PROSPERO, registration number CRD42017058776). The systematic review was carried out in accordance with the PRISMA checklist.
Inclusion and exclusion criteria
All studies assessing women classified as having a pregnancy of unknown location (PUL) at their initial ultrasound scan were included. Therefore, studies assessing pregnancies that were not a PUL at the initial ultrasound scan (i.e. an ectopic or confirmed intrauterine pregnancy) were excluded. Only studies written in the English language were included. All randomised control trials, case-control studies, cohort studies and observational studies were eligible for inclusion. These were both prospective and retrospective. All reviews, case reports and letters were excluded. Studies took place in both dedicated Early Pregnancy Assessment Units and hospital accident and emergency departments.
Identification of studies
A literature search was performed using MESH terms and predefined search strings on MEDLINE, COCHRANE and DARE databases from 1 January 1984 to 31 January 2017. MESH terms used were as follows: Pregnancy, Tubal [Majr] OR 'Pregnancy, Ectopic'[Majr] OR ectopic pregnancy OR PUL OR pregnancy of unknown location. Free text search strings were as follows: 'ectopic pregnancy OR pregnancy of unknown location'. A start date of 1 January 1984 was used because this was the year when transvaginal ultrasonography became part of routine early pregnancy assessment. Papers were also restricted to studies on humans and those written in the English language. The references of eligible papers and other systematic reviews on the topic were also assessed to find papers not identified in the initial database searches.
Selection of studies and data extraction
Two reviewers (SB and SS) evaluated potentially eligible papers in a three-step process. First, titles were screened (SB). If there was any doubt about eligibility, the paper was further screened in step two where the abstract was also reviewed (SB and SS). This was done to ensure that no papers were missed. The third step involved evaluating the full text of articles that had been selected (SB and SS). Two review authors (SB and SS) extracted the data from included studies using a standardised data extraction form designed by the authors. This included details on study characteristics (first author, year of publication, study groups); study methodology type (prospective or retrospective), design, study period, location (emergency department or dedicated Early Pregnancy Assessment Unit); details on the PUL definition used; the index test (management protocol used) and the recorded final clinical outcome of all PUL included in each study. We extracted binary diagnostic accuracy data and constructed 2 9 2 tables from all included studies and all thresholds reported in those studies. If available, 2 9 2 tables from each participating centre in multicentre studies were extracted per centre.
Risk of bias assessment
Two review authors (SB and SS) assessed the risk of bias in the included studies by using QUADAS-2 criteria. 40 Disagreements between the review authors over the risk of bias in particular studies were resolved by discussion, with the involvement of a third review author (TB) where necessary.
Outcomes of interest
The primary outcome of the study was the correct diagnosis of the final outcome (assessment of test performance). In the context of PUL, the final outcome can either be [1] EP, [2] FPUL, or [3] IUP (whether this be a VIUP or NVIUP). Persistent PUL was not assessed as a final outcome in any of the studies so this was not included in our data analysis.
Statistical analysis
We produced paired forest plots of sensitivity and specificity with corresponding 95% CI for each method measuring the three main outcomes of interest: EP, IUP and FPUL.
Considering that several studies reported more than one threshold and the corresponding values of sensitivity and specificity, we applied a novel parametric approach allowing several thresholds per study. 41 It is based on the idea of estimating the distribution functions of the underlying biomarker or method within the non-diseased and diseased individuals. Assuming a logistic distribution, it estimates the distribution parameters in both groups applying a linear mixed-effects model to the transformed data. The model accounts for between-study heterogeneity (random effect) and dependence of sensitivity and specificity. We used the inverse variance as previous weights of the studies scaled to mean one. Once the model parameters were estimated, the underlying distribution functions were determined. From these, we extracted the pooled sensitivity and specificity values at every relevant threshold. Summary receiver operating characteristic (ROC) curves to compare competing protocols were derived with corresponding 95% confidence regions and available thresholds were plotted on the summary receiver operating characteristic (SROC) curve. Areas under the Receiver Operating Characteristic curves (AUCs) were calculated using numerical integration over the areas in the SROC curves. We used the Deeks' funnel plot to analyse the likelihood of publication bias in our diagnostic meta-analysis, using the effective sample size funnel plot and associated regression test of asymmetry. 42 All analyses were performed using R version 3.2.4 and REVMAN version 5.3.
Core outcome sets
Core outcome sets do not exist for this topic.
Patient and public involvement
Patient and public involvement was not a part of this study. 
Study funding
Results
Study selection
Electronic database searches from MEDLINE, COCHRANE and DARE databases retrieved 8847 papers after the removal of duplicates. The flow of paper retrieval is summarised in Figure 1 . Ninety-nine papers were selected for full text review. Forty-three papers met the criteria for qualitative synthesis (systematic review). A total of 27 493 women with PUL were recruited, and 23 802 PUL were analysed in these studies. Thirty-seven papers met the criteria for quantitative synthesis (meta-analysis). Fifteen studies assessed the predictive value of single hCG cut-off levels, eight studies assessed the hCG ratio (hCG 48 hours/hCG at 0 hours), 12 studies assessed progesterone cut-off levels, two studies used a combination of hCG and progesterone levels, 16 studies assessed logistic regression models, which used a variety of predictive variables, five studies evaluated the value of endometrial thickness and four studies looked at novel biomarkers such as CA125, activin A and inhibin A. Of these studies, 30 were prospective and the remaining 13 were retrospective. Of the 37 studies included in the meta-analysis, 15 studies evaluated single hCG measurements, 8 studies evaluated the hCG ratio, 13 studies evaluated progesterone cut-offs and 8 studies used the M4 model. Meta-analysis could not be performed on additional logistic regression models because there were not enough studies on any other model.
Characteristics of included studies
The characteristics of the 43 studies selected for final analysis are summarised in the supplementary material (Table S1 ). The term PUL is not a final diagnosis, and therefore, there was a great deal of heterogeneity among papers not only in the definition of a PUL itself but in the definition of the potential final outcomes. 'PUL' was defined most commonly as a TVS showing no evidence of an IUP or EP in a woman presenting with a positive urine pregnancy test. Some papers extended this to include no TVS evidence of retained products of conception.
Not all studies evaluated all three (IUP, EP, FPUL) potential final outcomes. PPUL was not assessed in any of the studies as a final outcome so this was not included in our data analysis. An 'IUP' was usually defined as the presence of an intrauterine gestation sac on ultrasound AE confirmation of chorionic villi on histopathological examination of tissue removed during uterine curettage. Some studies differentiated between VIUP and NVIUP but most grouped them under the umbrella term of IUP. An 'EP' was most commonly defined as an extrauterine/adnexal mass seen on TVS. Some studies defined it as trophoblast tissue confirmed on histopathological examination of tissue removed after a salpingectomy. The term 'failed PUL' was not in common use before 1999 but met similar definitions to other terms such as 'trophoblast regression' used in earlier papers. Therefore, for the purposes of this analysis, 'trophoblast regression' was analysed as FPUL. Most studies defined 'FPUL' as persistent negative sonographic findings and the spontaneous resolution of a pregnancy with a decrease in hCG levels (usually to < 5 IU/l). Some papers also included an initial progesterone level of < 20 mmol/l in the definition.
Most studies defined specific inclusion and exclusion criteria but there was also heterogeneity among these. This is summarised in the supplementary material (Table S2 ).
Risk of bias within studies
The risk of bias was assessed using QUADAS-2 criteria 40 ( Figure 2 ). The index test refers to the management protocol being assessed. The reference standard refers to the reference standard test used to confirm a particular final outcome. The reference standard item in risk of bias was always deemed high risk because the reference standard varied depending on what the final outcome was (differential verification bias). For example, the reference standard for confirming an IUP is a TVS demonstrating an IUP with an embryo and a visible heart beat, whereas that for an EP could be confirmation of trophoblast tissue on histological examination of a fallopian tube post-salpingectomy. The only instance where this was low risk was where all women underwent the same reference test/intervention, for example uterine curettage.
Diagnostic performance of management protocols for PUL
The diagnostic performance of each management protocol for each of the three potential final outcomes (EP, IUP, FPUL) is summarised in the supplementary material (Table S3 ). The paired forest plots of sensitivity and specificity of each study for the different outcome categories are presented in the supplementary material ( Figure S1 ) and summarised in Table 1 .
Meta-analysis: primary outcome
Predicting a final outcome of EP A final outcome of EP puts women classified as a PUL at most risk of clinical complications and harm. Therefore, this remains the most important outcome to accurately predict and rule out. The supplementary material shows summary ROC curves for the test performance of single hCG cut-offs ( Figure S2 ), for the hCG ratio ( Figure S3 ), for progesterone cut-offs ( Figure S4 ) and for the M4 risk prediction model ( Figure S5 ). Summary analysis of all methods used to predict EP as a final outcome demonstrated single hCG cut-offs had an AUC of 0.42 (95% CI 0.00-0.99), the hCG ratio had an AUC of 0.69 (95% CI 0.57-0.78), and progesterone cut-offs had an AUC of 0.69 (95% CI 0.54-0.81). The test performance for the M4 model was associated with an AUC of 0.87 (95% CI 0.83-0.91) (Figure 3) . Pooled sensitivity and specificity data for the management protocols are summarised in Table 1 . Predicting a final outcome of FPUL Summary analysis of all methods used to predict FPUL as a final outcome showed that single hCG cut-offs had an AUC of 0.59 (95% CI 0.00-1.00), progesterone cut-offs had an AUC of 0.87 (95% CI 0.76-0.94), and the M4 prediction model had an AUC of 0.84 (95% CI 0.15-1.00). The AUC for the hCG ratio was 0.98 (95% CI 0.86-1.00) (see supplementary material, Figure S7 ).
Assessment of publication bias
We found no evidence of publication bias, apart from the studies on hCG ratio for FPUL, although this was probably due to the low number of studies (n = 2) available for analysis (see supplementary material, Figures S8-S10 ).
Sub-group analyses
As described in the protocol, subgroup analyses were performed for the different biomarker methods. Due to the paucity of data for each combination of method and outcome, no subgroup analyses for QUADAS items were possible.
Discussion
Main findings
This is the first systematic review to assess all published management protocols for women with a PUL, providing healthcare professionals with a comprehensive summary of the current evidence on a clinical scenario that is often difficult to manage. Although we primarily identified studies with a high risk of verification bias, due to differences in final outcome assessment, we have shown that the M4 model, a logistic regression model, performed better than other management protocols in predicting a final outcome of EP (AUC 0.87). It is also a good discriminator of failing pregnancies (AUC 0.84) and ongoing IUP (AUC 0.86). Accordingly, the M4 model can guide clinicians to safely follow up these low risk PUL less intensively, reducing the need for unnecessary tests or treatment. Conversely, PUL predicted to be EP can be more closely monitored. The AUCs for predicting viable IUP or FPUL using both the hCG ratio and measurements of serum progesterone are better than the M4 model but these two protocols are both limited by having an AUC for the correct prediction of EP of only 0.69.
The majority of women with a PUL will be at low risk of complications (i.e. a final outcome of IUP or FPUL). A delay in the diagnosis of an EP in a PUL, however, can lead to maternal morbidity and mortality. 43 It is therefore clinically important to rationalise the management of PUL while retaining a high level of test performance for predicting a final outcome of EP. The test performance of any protocol, however, will be influenced by the population in which it is used, the available resources and the PUL rate (the number of women classified as having a PUL/all early pregnancy patients scanned in a unit, it is generally accepted that a 'good' PUL rate is < 15% 44 ).
Strengths and limitations
These data were extremely heterogeneous in the way that PUL was defined, how final outcomes were defined and how data were presented and analysed. There was also variance in the management protocols. For example, studies did not just assess one hCG cut-off but several different ones. We, however, applied a novel approach taking into account these multiple thresholds per study, allowing us to The summary AUC column provides an overall AUC for all thresholds analysed within that management protocol, not just that which is specified in the 'threshold' column. incorporate all available evidence and not limit analyses to an arbitrarily chosen threshold per study.
Interpretation
It is important to remember that management protocols for PUL are meant to be predictive and not diagnostic. 
Conclusions
A number of management protocols exist for the management of PUL and this systematic review and meta-analysis provides a summary of the current best evidence. All available protocols have limitations. The hCG ratio and single measurements of progesterone are good at predicting viability but relatively poor at predicting a final outcome of an ectopic pregnancy. The M4 model is marginally less capable when predicting viability but better at predicting ectopic pregnancy. Overall, the M4 model appeared to have the best test performance (the M4 model is freely available at http://www.earlypregnancycare.com/m4triage). The use of any management protocol needs to be generalisable and multicentre studies would suggest that the M4 model has broad utility. 23, 27 Focusing further on refining and validating the use of risk prediction models is likely to be the best way forward in rationalising the management of PUL.
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